- •Preface and Acknowledgments
- •Contents
- •Contributors
- •1: Embryology for Urologists
- •Introduction
- •Renal Development
- •Pronephros
- •Mesonephros
- •Metanephros
- •Development of the Collecting System
- •Critical Steps in Further Development
- •Anomalies of the Kidney
- •Renal Agenesis
- •Renal Aplasia
- •Renal Hypoplasia
- •Renal Ectopia
- •Renal Fusion
- •Ureteral Development
- •Anomalies of Origin
- •Anomalies of Number
- •Incomplete Ureteral Duplication
- •Complete Ureteral Duplication
- •Ureteral Ectopia
- •Embryology of Ectopia
- •Clinical Correlation
- •Location of Ectopic Ureteral Orifices – Male (in Descending Order According to Incidence)
- •Symptoms
- •Ureteroceles
- •Congenital Ureteral Obstruction
- •Pipestem Ureter
- •Megaureter-Megacystis Syndrome
- •Prune Belly Syndrome
- •Vascular Ureteral Obstructions
- •Division of the Urogenital Sinus
- •Bladder Development
- •Urachal Anomalies
- •Cloacal Duct Anomalies
- •Other Bladder Anomalies
- •Bladder Diverticula
- •Bladder Extrophy
- •Gonadal Development
- •Testicular Differentiation
- •Ovarian Differentiation
- •Gonadal Anomalies
- •Genital Duct System
- •Disorders of Testicular Function
- •Female Ductal Development
- •Prostatic Urethral Valves
- •Gonadal Duct Anomalies
- •External Genital Development
- •Male External Genital Development
- •Female External Genital Development
- •Anomalies of the External Genitalia
- •References
- •2: Gross and Laparoscopic Anatomy of the Upper Urinary Tract and Retroperitoneum
- •Overview
- •The Kidneys
- •The Renal Vasculature
- •The Renal Collecting System
- •The Ureters
- •Retroperitoneal Lymphatics
- •Retroperitoneal Nerves
- •The Adrenal Glands
- •References
- •3: Gross and Laparoscopic Anatomy of the Lower Urinary Tract and Pelvis
- •Introduction
- •Female Pelvis
- •Male Pelvis
- •Pelvic Floor
- •Urinary Bladder
- •Urethra
- •Male Urethra
- •Female Urethra
- •Sphincter Mechanisms
- •The Bladder Neck Component
- •The Urethral Wall Component
- •The External Urethral Sphincter
- •Summary
- •References
- •4: Anatomy of the Male Reproductive System
- •Testis and Scrotum
- •Spermatogenesis
- •Hormonal Regulation of Spermatogenesis
- •Genetic Regulation of Spermatogenesis
- •Epididymis and Ductus Deferens
- •Accessory Sex Glands
- •Prostate
- •Seminal Vesicles
- •Bulbourethral Glands
- •Penis
- •Erection and Ejaculation
- •References
- •5: Imaging of the Upper Tracts
- •Anatomy of the Upper Tracts and Introduction to Imaging Modalities
- •Introduction
- •Renal Upper Tract Basic Anatomy
- •Modalities Used for Imaging the Upper Tracts
- •Ultrasound
- •Radiation Issues
- •Contrast Issues
- •Renal and Upper Tract Tumors
- •Benign Renal Tumors
- •Transitional Cell Carcinoma
- •Renal Mass Biopsy
- •Renal Stone Disease
- •Ultrasound
- •Plain Radiographs and IVU
- •Renal Cystic Disease
- •Benign Renal Cysts
- •Hereditary Renal Cystic Disease
- •Complex Renal Cysts
- •Renal Trauma
- •References
- •Introduction
- •Pathophysiology
- •Susceptibility and Resistance
- •Epidemiological Breakpoints
- •Clinical Breakpoints
- •Pharmacodynamic Parameters
- •Pharmacokinetic Parameters
- •Fosfomycin
- •Nitrofurantoin
- •Pivmecillinam
- •b-Lactam-Antibiotics
- •Penicillins
- •Cephalosporins
- •Carbapenems
- •Aminoglycosides
- •Fluoroquinolones
- •Trimethoprim, Cotrimoxazole
- •Glycopeptides
- •Linezolid
- •Conclusion
- •References
- •7: An Overview of Renal Physiology
- •Introduction
- •Body Fluid Compartments
- •Regulation of Potassium Balance
- •Regulation of Acid–Base Balance
- •Diuretics
- •Suggested Reading
- •8: Ureteral Physiology and Pharmacology
- •Ureteral Anatomy
- •Modulation of Peristalsis
- •Ureteral Pharmacology
- •Conclusion
- •References
- •Introduction
- •Afferent Signaling Pathways
- •Efferent Signaling
- •Parasympathetic Nerves
- •Sympathetic Nerves
- •Vesico-Spinal-Vesical Micturition Reflex
- •Peripheral Targets
- •Afferent Signaling Mechanisms
- •Urothelium
- •Myocytes
- •Cholinergic Receptors
- •Muscarinic Receptors
- •Nicotinic Receptors
- •Adrenergic Receptors (ARs)
- •a-Adrenoceptors
- •b-Adrenoceptors
- •Transient Receptor Potential (TRP) Receptors
- •Phosphodiesterases (PDEs)
- •CNS Targets
- •Opioid Receptors
- •Serotonin (5-HT) Mechanisms
- •g-Amino Butyric Acid (GABA) Mechanisms
- •Gabapentin
- •Neurokinin and Neurokinin Receptors
- •Summary
- •References
- •10: Pharmacology of Sexual Function
- •Introduction
- •Sexual Desire/Arousal
- •Endocrinology
- •Steroids in the Male
- •Steroids in the Female
- •Neurohormones
- •Neurotransmitters
- •Dopamine
- •Serotonin
- •Pharmacological Strategies
- •CNS Drugs
- •Enzyme-inducing Antiepileptic Drugs
- •Erectile Function
- •Ejaculatory Function
- •Premature Ejaculation
- •Abnormal Ejaculation
- •Conclusions
- •References
- •Epidemiology
- •Calcium-Based Urolithiasis
- •Uric Acid Urolithiasis
- •Infectious Urolithiasis
- •Cystine-Based Urolithiasis
- •Aims
- •Who Deserves Metabolic Evaluation?
- •Metabolic Workup for Stone Producers
- •Medical History and Physical Examination
- •Stone Analysis
- •Serum Chemistry
- •Urine Evaluation
- •Urine Cultures
- •Urinalysis
- •Twenty-Four Hour Urine Collections
- •Radiologic Imaging
- •Medical Management
- •Conservative Management
- •Increased Fluid Intake
- •Citrus Juices
- •Dietary Restrictions
- •Restricted Oxalate Diet
- •Conservative Measures
- •Selective Medical Therapy
- •Absorptive Hypercalciuria
- •Thiazide
- •Orthophosphate
- •Renal Hypercalciuria
- •Primary Hyperparathyroidism
- •Hyperuricosuric Calcium Oxalate Nephrolithiasis
- •Enteric Hyperoxaluria
- •Hypocitraturic Calcium Oxalate Nephrolithiasis
- •Distal Renal Tubular Acidosis
- •Chronic Diarrheal States
- •Thiazide-Induced Hypocitraturia
- •Idiopathic Hypocitraturic Calcium Oxalate Nephrolithiasis
- •Hypomagnesiuric Calcium Nephrolithiasis
- •Gouty Diathesis
- •Cystinuria
- •Infection Lithiasis
- •Summary
- •References
- •12: Molecular Biology for Urologists
- •Introduction
- •Inherited Changes in Cancer Cells
- •VEGR and Cell Signaling
- •Targeting mTOR
- •Conclusion
- •References
- •13: Chemotherapeutic Agents for Urologic Oncology
- •Introduction
- •Bladder Cancer
- •Muscle Invasive Bladder Cancer
- •Metastatic Bladder Cancer
- •Conclusion
- •Prostate Cancer
- •Other Chemotherapeutic Drugs or Combinations for Treating HRPC
- •Conclusion
- •Renal Cell Carcinoma
- •Chemotherapy
- •Immunotherapy
- •Angiogenesis Inhibitor Drugs
- •Conclusion
- •Testicular Cancer
- •Stage I Seminoma
- •Stage I non-seminomatous Germ Cell Tumours (NSGCT)
- •Metastatic Germ Cell Tumours
- •Low-Volume Metastatic Disease (Stage II A/B)
- •Advanced Metastatic Disease
- •Salvage Chemotherapy for Relapsed or Refractory Disease
- •Conclusion
- •Penile Cancer
- •Side Effects of Chemotherapy
- •Conclusion
- •References
- •14: Tumor and Transplant Immunology
- •Antibodies
- •Cytotoxic and T-helper Cells
- •Immunosuppression
- •Induction Therapy
- •Maintenance Therapy
- •Rejection
- •Posttransplant Lymphoproliferative Disease
- •Summary
- •References
- •15: Pathophysiology of Renal Obstruction
- •Causes of Renal Obstruction
- •Effects on Prenatal Development
- •Prenatal Hydronephrosis
- •Spectrum of Renal Abnormalities
- •Renal Functional Changes
- •Renal Growth/Counterbalance
- •Vascular Changes
- •Inflammatory Mediators
- •Glomerular Development Changes
- •Mechanical Stretch of Renal Tubules
- •Unilateral Versus Bilateral
- •Limitations of Animal Models
- •Future Research
- •Issues in Patient Management
- •Diagnostic Imaging
- •Ultrasound
- •Intravenous Urography
- •Antegrade Urography and the Whitaker Test
- •Nuclear Renography
- •Computed Tomography
- •Magnetic Resonance Urography
- •Hypertension
- •Postobstructive Diuresis
- •References
- •Introduction
- •The Normal Lower Urinary Tract
- •Anatomy
- •Storage Function
- •Voiding Function
- •Neural Control
- •Symptoms
- •Flow Rate and Post-void Residual
- •Voiding Cystometry
- •Male
- •Female
- •Neurourology
- •Conclusions
- •References
- •17: Urologic Endocrinology
- •The Testis
- •Normal Androgen Metabolism
- •Epidemiological Aspects
- •Prostate
- •Brain
- •Muscle Mass and Adipose Tissue
- •Bones
- •Ematopoiesis
- •Metabolism
- •Cardiovascular System
- •Clinical Assessment
- •Biochemical Assessment
- •Treatment Modalities
- •Oral Preparations
- •Parenteral Preparations
- •Transdermal Preparations
- •Side Effects and Treatment Monitoring
- •Body Composition
- •Cognitive Decline
- •Bone Metabolism
- •The Kidneys
- •Endocrine Functions of the Kidney
- •Erythropoietin
- •Calcitriol
- •Renin
- •Paraneoplastic Syndromes
- •Hypercalcemia
- •Hypertension
- •Polycythemia
- •Other Endocrine Abnormalities
- •References
- •General Physiology
- •Prostate Innervation
- •Summary
- •References
- •Wound Healing
- •Inflammation
- •Proliferation
- •Remodeling
- •Principles of Plastic Surgery
- •Tissue Characteristics
- •Grafts
- •Flap
- •References
- •Lower Urinary Tract Symptoms
- •Storage Phase
- •Voiding Phase
- •Return to Storage Phase
- •Urodynamic Parameters
- •Urodynamic Techniques
- •Volume Voided Charts
- •Pad Testing
- •Typical Test Schedule
- •Uroflowmetry
- •Post Voiding Residual
- •Further Diagnostic Evaluation of Patients
- •Cystometry with or Without Video
- •Cystometry
- •Videocystometrography (Cystometry + Cystourethrography)
- •Cystometric Findings
- •Comment:
- •Measurements During the Storage Phase:
- •Measurements During the Voiding Phase:
- •Abnormal Function
- •Disorders of Sensation
- •Causes of Hypersensitive Bladder Sensation
- •Causes of Hyposensitive Bladder Sensation
- •Disorders of Detrusor Motor Function
- •Bladder Outflow Tract Dysfunction
- •Detrusor–Urethral Dyssynergia
- •Detrusor–Bladder Neck Dyssynergia
- •Detrusor–Sphincter Dyssynergia
- •Complex Urodynamic Investigation
- •Urethral Pressure Measurement
- •Technique
- •Neurophysiological Evaluation
- •Conclusion
- •References
- •Endoscopy
- •Cystourethroscopy
- •Ureteroscopy and Ureteropyeloscopy
- •Nephroscopy
- •Virtual Reality Simulators
- •Lasers
- •Clinical Application of Lasers
- •Condylomata Acuminata
- •Urolithiasis
- •Benign Prostatic Hyperplasia
- •Ureteral and Urethral Strictures
- •Conclusion
- •References
- •Introduction
- •The Prostatitis Syndromes
- •The Scope of the Problem
- •Category III CP/CPPS
- •The Goal of Treatment
- •Conservative Management
- •Drug Therapy
- •Antibiotics
- •Anti-inflammatories
- •Alpha blockers
- •Hormone Therapies
- •Phytotherapies
- •Analgesics, muscle relaxants and neuromodulators
- •Surgery
- •A Practical Management Plan
- •References
- •Orchitis
- •Definition and Etiology
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation
- •Treatment of Infectious Orchitis
- •Epididymitis
- •Definition and Etiology
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation of Epididymitis
- •Treatment of Acute Epididymitis
- •Treatment of Chronic Epididymitis
- •Treatment of Spermatic Cord Torsion
- •Fournier’s Gangrene
- •Definition and Etiology
- •Risk Factors
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation
- •Treatment
- •References
- •Fungal Infections
- •Candidiasis
- •Aspergillosis
- •Cryptococcosis
- •Blastomycosis
- •Coccidioidomycosis
- •Histoplasmosis
- •Radiographic Findings
- •Treatment
- •Tuberculosis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Schistosomiasis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Filariasis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Onchocerciasis
- •References
- •25: Sexually Transmitted Infections
- •Introduction
- •STIs Associated with Genital Ulcers
- •Herpes Simplex Virus
- •Diagnosis
- •Treatment
- •Chancroid
- •Diagnosis
- •Treatment
- •Syphilis
- •Diagnosis
- •Treatment
- •Lymphogranuloma Venereum
- •Diagnosis
- •Treatment
- •Chlamydia
- •Diagnosis
- •Treatment
- •Gonorrhea
- •Diagnosis
- •Treatment
- •Trichomoniasis
- •Diagnosis
- •Treatment
- •Human Papilloma Virus
- •Diagnosis
- •Treatment
- •Scabies
- •Diagnosis
- •Treatment
- •References
- •26: Hematuria: Evaluation and Management
- •Introduction
- •Classification of Hematuria
- •Macroscopic Hematuria
- •Microscopic Hematuria
- •Dipstick Hematuria
- •Pseudohematuria
- •Factitious Hematuria
- •Menstruation
- •Aetiology
- •Malignancy
- •Urinary Calculi
- •Infection and Inflammation
- •Benign Prostatic Hyperplasia
- •Trauma
- •Drugs
- •Nephrological Causes
- •Assessment
- •History
- •Examination
- •Investigations
- •Dipstick Urinalysis
- •Cytology
- •Molecular Tests
- •Blood Tests
- •Flexible Cystoscopy
- •Upper Urinary Tract Evaluation
- •Renal USS
- •KUB Abdominal X-Ray
- •Intravenous Urography (IVU)
- •Computed Tomography (CT)
- •Retrograde Urogram Studies
- •Magnetic Resonance Imaging (MRI)
- •Additional Tests and Renal Biopsy
- •Intractable Hematuria
- •Loin Pain Hematuria Syndrome
- •References
- •27: Benign Prostatic Hyperplasia (BPH)
- •Historical Background
- •Pathophysiology
- •Patient Assessment
- •Treatment of BPH
- •Watchful Waiting
- •Drug Therapy
- •Interventional Therapies
- •Conclusions
- •References
- •28: Practical Guidelines for the Treatment of Erectile Dysfunction and Peyronie´s Disease
- •Erectile Dysfunction
- •Introduction
- •Diagnosis
- •Basic Evaluation
- •Cardiovascular System and Sexual Activity
- •Optional Tests
- •Treatment
- •Medical Treatment
- •Oral Agents
- •Phosphodiesterase Type 5 (PDE 5) Inhibitors
- •Nonresponders to PDE5 Inhibitors
- •Apomorphine SL
- •Yohimbine
- •Intracavernosal and Intraurethral Therapy
- •Intracavernosal Injection (ICI) Therapy
- •Intraurethral Therapy
- •Vacuum Constriction Devices
- •Surgical Therapy
- •Conclusion
- •Peyronie´s Disease (PD)
- •Introduction
- •Oral Drug Therapy
- •Intralesional Drug Therapy
- •Iontophoresis
- •Radiation Therapy
- •Surgical Therapy
- •References
- •29: Premature Ejaculation
- •Introduction
- •Epidemiology
- •Defining Premature Ejaculation
- •Voluntary Control
- •Sexual Satisfaction
- •Distress
- •Psychosexual Counseling
- •Pharmacological Treatment
- •On-Demand Treatment with Tramadol
- •Topical Anesthetics
- •Phosphodiesterase Inhibitors
- •Surgery
- •Conclusion
- •References
- •30: The Role of Interventional Management for Urinary Tract Calculi
- •Contraindications to ESWL
- •Complications of ESWL
- •PCNL Access
- •Instrumentation for PCNL
- •Nephrostomy Drains Post PCNL
- •Contraindications to PCNL
- •Complications of PCNL
- •Semirigid Ureteroscopy
- •Flexible Ureteroscopy
- •Electrohydraulic Lithotripsy (EHL)
- •Ultrasound
- •Ballistic Lithotripsy
- •Laser Lithotripsy
- •Ureteric Stents
- •Staghorn Calculi
- •Lower Pole Stones
- •Horseshoe Kidneys and Stones
- •Calyceal Diverticula Stones
- •Stones and PUJ Obstruction
- •Treatment of Ureteric Colic
- •Medical Expulsive Therapy (MET)
- •Intervention for Ureteric Stones
- •Stones in Pregnancy
- •Morbid Obesity
- •References
- •Anatomy and Function
- •Pathophysiology
- •Management
- •Optical Urethrotomy/Dilatation
- •Urethral Stents
- •Preoperative Assessment
- •Urethroplasty
- •Anastomotic Urethroplasty
- •Substitution Urethroplasty
- •Grafts Versus Flaps
- •Oral Mucosal Grafts
- •Tissue Engineering
- •Graft Position
- •Conclusion
- •References
- •32: Urinary Incontinence
- •Epidemiology and Risk Factors
- •Pathophysiology
- •Urge Incontinence
- •Conservative Treatments
- •Pharmacotherapy
- •Invasive/ Surgical Therapies
- •Stress Urinary Incontinence
- •Male SUI Therapies
- •Female SUI Therapies
- •Mixed Urinary Incontinence
- •Conclusions
- •References
- •33: Neurogenic Bladder
- •Introduction
- •Examination and Diagnostic Tests
- •History and Physical Examination
- •Imaging
- •Urodynamics (UDS)
- •Evoked Potentials
- •Classifications
- •Somatic Pathways
- •Brain Lesions
- •Cerebrovascular Accident (CVA)
- •Parkinson’s Disease (PD)
- •Multiple Sclerosis
- •Huntington’s Disease
- •Dementias
- •Normal Pressure Hydrocephalus (NPH)
- •Tumors
- •Psychiatric Disorders
- •Spinal Lesions and Pathology
- •Intervertebral Disk Prolapse
- •Spinal Cord Injury (SCI)
- •Transverse Myelitis
- •Peripheral Neuropathies
- •Metabolic Neuropathies
- •Pelvic Surgery
- •Treatment
- •Summary
- •References
- •34: Pelvic Prolapse
- •Introduction
- •Epidemiology
- •Anatomy and Pathophysiology
- •Evaluation and Diagnosis
- •Outcome Measures
- •Imaging
- •Urodynamics
- •Indications for Management
- •Biosynthetics
- •Surgical Management
- •Anterior Compartment Repair
- •Uterine/Apical Prolapse
- •Enterocele Repair
- •Conclusion
- •References
- •35: Urinary Tract Fistula
- •Introduction
- •Urogynecologic Fistula
- •Vesicovaginal Fistula
- •Etiology and Risk Factors
- •Clinical Factors
- •Evaluation and Diagnosis
- •Pelvic Examination
- •Cystoscopy
- •Imaging
- •Treatment
- •Conservative Management
- •Surgical Management
- •Urethrovaginal Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Ureterovaginal Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Vesicouterine Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Uro-Enteric Fistula
- •Vesicoenteric Fistula
- •Pyeloenteric Fistula
- •Urethrorectal Fistula
- •References
- •36: Urologic Trauma
- •Introduction
- •Kidney
- •Expectant Management
- •Endovascular Therapy
- •Operative Intervention
- •Operative Management: Follow-up
- •Reno-Vascular Injuries
- •Pediatric Renal Injuries
- •Adrenal
- •Ureter
- •Diagnosis
- •Treatment
- •Delayed Diagnosis
- •Bladder and Posterior Urethra
- •Bladder Injuries: Initial Management
- •Bladder Injuries: Formal Repair
- •Anterior Urethral Trauma
- •Fractured Penis
- •Penile Amputation
- •Scrotal and Testicular Trauma
- •Imaging
- •CT-IVP (CT with Delayed Images)
- •Technique
- •Cystogram
- •Technique
- •Retrograde Urethrogram (RUG)
- •Technique
- •Retrograde Pyelogram (RPG)
- •Technique
- •One-Shot IVP
- •Technique
- •References
- •37: Bladder Cancer
- •Who Should Be Investigated?
- •Epidemiology
- •Risk Factors
- •Role of Screening
- •Signs and Symptoms
- •Imaging
- •Cystoscopy
- •Urine Tests
- •PDD-Assisted TUR
- •Pathology
- •NMIBC and Risk Groups
- •Intravesical Chemotherapy
- •Intravesical Immunotherapy
- •Immediate Cystectomy and CIS
- •Radical Cystectomy with Pelvic Lymph Node Dissection
- •sexual function-preserving techniques
- •Bladder-Preservation Treatments
- •Neoadjuvant Chemotherapy
- •Adjuvant Chemotherapy
- •Preoperative Radiotherapy
- •Follow-up After TUR in NMIBC
- •References
- •38: Prostate Cancer
- •Introduction
- •Epidemiology
- •Race
- •Geographic Variation
- •Risk Factors and Prevention
- •Family History
- •Diet and Lifestyle
- •Prevention
- •Screening and Diagnosis
- •Current Screening Recommendations
- •Biopsy
- •Pathology
- •Prognosis
- •Treatment of Prostate Cancer
- •Treatment for Localized Prostate Cancer (T1, T2)
- •Radical Prostatectomy
- •EBRT
- •IMRT
- •Brachytherapy
- •Treatment for Locally Advanced Prostate Cancer (T3, T4)
- •EBRT with ADT
- •Radical Prostatectomy
- •Androgen-Deprivation Therapy
- •Summary
- •References
- •39: The Management of Testis Cancer
- •Presentation and Diagnosis
- •Serum Tumor Markers
- •Primary Surgery
- •Testis Preserving Surgery
- •Risk Stratification
- •Surveillance Versus Primary RPLND
- •Primary RPLND
- •Adjuvant Treatment for High Risk
- •Clinical Stage 1 Seminoma
- •Risk-Stratified Adjuvant Treatment
- •Adjuvant Radiotherapy
- •Adjuvant Low Dose Chemotherapy
- •Primary Combination Chemotherapy
- •Late Toxicity
- •Salvage Strategies
- •Conclusion
- •References
- •Index
30
The Role of Interventional Management for Urinary Tract Calculi
Kenneth J. Hastie
The treatment of urinary tract stone disease has been revolutionized over the last 3 decades with the major technological advances of extracorporeal shock wave lithotripsy, percutaneous renal surgery, and ureteroscopy. These have not only made open surgery virtually obsolete but undoubtedly have lowered the threshold for intervention.
The principles and technical aspects of these modern minimally invasive methods for treating calculi are discussed and then how these modalities are applied to specific stone scenarios are described.
Extracorporeal Shock Wave
Lithotripsy (ESWL)
The concept of using shock waves to shatter kidney stones was proposed by Chaussy et al. in 1980.1 As a result of the clinical introduction of this technique in the early part of that decade, the management of urinary tract stone disease was transformed. There are three major types of shock wave generator in common usage: electrohydraulic, piezoelectric, and electromagnetic.
The general principle common to all is the generation of a shock wave in a fluid. Typically, the shock wave is characterized by a rapid positive pressure followed by a shorter and shallower negative pressure component. The first
focal point (F1) is at the site of shock wave generation. A focusing device is required to converge the shock waves onto the stone for fragmentation (F2).
Electrohydraulic systems rely on the discharge of a high-voltage current across a spark gap. This results in an expanding gas bubble which creates a shock wave. This is focused by a metallic semiellipsoid which surrounds the generator. The pressures achieved do vary (perhaps by as much as 45%), and the spark gap electrode has a finite life span. There is a risk of cardiac arrhythmias with this shock wave generator and to avoid this ECG gating is required. This ensures that the shock wave occurs after the R wave during the refractory period of the cardiac cycle.
Piezoelectric lithotripters depend on the property that ceramic crystals have a characteristic frequency of resonance. When a highvoltage current is applied, the crystal vibrates producing a shock wave that can be propagated in water. This type of lithotripter has a large number of such elements in a hemispherical array which acts as a self-focusing device. The analgesic requirements are less with this technology and it is accepted that stone fragmentation is slower with a greater retreatment rate.
The basic principle of electromagnetic lithotripsy is the application of an electric current to an electromagnetic coil within a water-filled cylinder. The ensuing magnetic field repels a metallic membrane producing a shock wave
C.R. Chapple and W.D. Steers (eds.), Practical Urology: Essential Principles and Practice, |
403 |
DOI: 10.1007/978-1-84882-034-0_30, © Springer-Verlag London Limited 2011 |
|
|
|
|
404 |
|
|
|
|
||
|
|
Practical Urology: EssEntial PrinciPlEs and PracticE |
||
which is focused using an acoustic lens. An |
suspected and ESWL is less effective for certain |
|||
alternative design is to surround the coil by a |
harder stone types (cystine and calcium oxalate |
|||
membrane in a cylindrical configuration. This |
monohydrate). |
|
||
in turn is surrounded by a parabolic reflector |
|
|
||
which focuses the shock wave at F2. This |
Complications of ESWL |
|
||
arrangement, as it has a hollow center, lends |
|
|||
itself to the addition of in-line ultrasound. |
Patients undergoing ESWL for renal stones will |
|||
Neither the electromagnetic nor the piezo- |
||||
have transient hematuria and there is the possi- |
||||
ceramic devices require ECG gating. |
||||
bility of a significant perirenal hematoma (0.5%) |
||||
Coupling of the patient to the shockwave gen- |
||||
and obstruction due to stone fragments (stein- |
||||
erator is necessary for transmission of the shock |
||||
strasse) within the ureter. The latter can resolve |
||||
wave. With the first Dornier lithotripters, cou- |
||||
given time but other interventions such as uret- |
||||
pling was achieved by fully immersing the |
||||
eroscopy or further ESWL to the lead fragment |
||||
patient within a water bath. This has now been |
||||
may be required. Prestenting the |
patient for |
|||
refined by the use of cushioned fluid-filled bags |
||||
larger stones (>1.5) can prevent obstruction, but |
||||
which when applied to the skin couple the shock |
||||
the presence of a stent does not necessarily help |
||||
waves to the patient using appropriate jelly to |
||||
the passage of stone fragments and the patient |
||||
ensure good contact. |
||||
has to accept stent symptoms. The use of alter- |
||||
Implicit in ESWL is a requirement for target- |
||||
natives such as PCNL should be considered if |
||||
ing. This is achieved by radiographic imaging in |
||||
the stone burden is large. |
|
|||
two planes or by in-line ultrasound. Clearly, the |
|
|||
Urosepsis is a potential complication as bac- |
||||
latter has safety advantages but requires further |
||||
teria can be released during treatment and it is |
||||
expertise. Ultrasound is a prerequisite for radio- |
||||
advised to treat UTI with antibiotics prior to |
||||
lucent stones. |
||||
ESWL. |
|
|||
With modern lithotripters, only simple anal- |
|
|||
Long-term concerns following |
lithotripsy |
|||
gesics such as nonsteroidal anti-inflammatory |
||||
have included suggestions that hypertension |
||||
drugs (NSAIDs) are required in most cases, but |
||||
and the development of diabetes.2 |
|
|||
children may require general anesthesia. |
|
|
||
When a shock wave reaches an interface |
Percutaneous Nephrolithotomy |
|||
such as at the surface of the stone the energy is |
||||
|
|
|||
released.A variety of theories have been postu- |
(PCNL) |
|
||
lated as to how shock waves cause fragmenta- |
|
|||
tion. These include the production of gaseous |
|
|
||
cavitation bubbles forming as a result of the |
This technique was first proposed by Ferntrom |
|||
negative pressure immediately following the |
and Johansson in 19763 and became standard |
|||
shock wave. The positive pressure of the wave |
practice for renal stones from the 1980s.4 |
|||
may cause fractures at the proximal surface of |
The principles of PCNL are access to the pel- |
|||
the stone. There may be reflection of the shock |
vicalyceal system allowing passage of a nephro- |
|||
wave within the stone and at the distal surface |
scope and the application of instruments for |
|||
at the stone/urine interface changing the shock |
stone fragmentation and removal. |
|
||
wave to a tensile wave causing stone disinte- |
Prior to planning PCNL, it is recommended |
|||
gration by spallation. Studies have suggested |
that in cases of complex stones, renal function |
|||
that slower shock wave rates at 60 shocks/min |
on the affected side is checked with renography |
|||
are more effective than higher rates of up to |
to ensure that the level of function warrants |
|||
120/min. |
treatment of the stone. Serious consideration |
|||
|
|
should be given to nephrectomy if ipsilateral |
||
Contraindications to ESWL |
function is less than 15–20% assuming the con- |
|||
|
|
tralateral kidney is normal. |
|
|
Certain factors related to patients may preclude |
Positive urine cultures prior to PCNL should |
|||
ESWL: these include bleeding diatheses and |
be treated and if at the time of surgery, the kid- |
|||
anticoagulation, pregnancy and aortic aneu- |
ney is found to contain purulent urine, the pro- |
|||
rysm. They can be issues with certain cardiac |
cedure should be abandoned and a nephrostomy |
|||
pacemakers. Caution is required if sepsis is |
drain left in situ. |
|
405
thE rolE of intErvEntional ManagEMEnt for Urinary tract calcUli
PCNL Access
Variations in patient position are described with the commonest being the prone position. The safest and easiest access is via a posterior lower pole calyx, but the route into the pelvicalyceal system will be determined by the configuration of the stone and is also facilitated by knowledge of the anatomy. Intravenous urography does give valuable information for both aspects. However in complex cases (e.g., staghorn calculi), special circumstances such as anatomical variants (e.g., horseshoe kidney) or certain patient types including spina bifida, CT scanning can be invaluable. Preand postcontrast CT with reconfiguration allows the access strategy to be planned in advance.
A number of radiological techniques are popular in facilitating access to the pelvicalyceal system for PCNL.
In the first method, a retrograde catheter is passed cystoscopically into the collecting system and this allows injection of a mixture of contrast and visible dye such as methylene blue. The former opacifies the system for x-ray screening and the latter gives the operator visible confirmation that the pelvicalyceal system has been punctured.
The second method depends on direct puncture of the pelvicalyceal system under ultrasound guidance. Third, an intravenous injection of contrast may be given and, after the pelvicalyceal system is opacified by any of these methods, access may proceed.
When the pelvicalyceal system is visible, it is punctured as previously planned,ideally through calyx and a guidewire may then be introduced through the needle into the kidney. It is recommended that every effort should be made to feed the wire into the ureter ideally as far as the bladder to prevent loss of the wire. If this is not possible, the wire is coiled within the collecting system. Some advocate the use of a second safety wire as a precaution in case the first wire is displaced. The tract is then dilated using one of a number of methods: serial dilators, the coaxial metal Alken dilators, and balloon dilatation. The latter has the advantages of speed and possibly less blood loss. However, the tapered configuration of the balloon can leave the dilated tract short of the target in certain circumstances (calyceal diverticulum, complete staghorn), and in these circumstances coaxial dilators have an
advantage as they are not tapered. Typically, the tract is dilated to 30 F and access to the system is achieved by placing a 30 F Amplatz sheath over the dilator and leaving it in situ. In complex cases, a second tract may be created.
Refinements such as the mini-PCNL using smaller caliber instruments (15 F access and 12 F Nephroscopes) are proposed for smaller stones and ESWL failures.5 Other than the potential for reduced complication rates no clear benefit of this technique has been shown. The disadvantages may include a longer operating time and the need to acquire further specialized instruments.
Instrumentation for PCNL
Rigid nephroscopes with an offset lens are standard for PCNL. These have large instrument channels allowing deployment of fragmentation probes and retrieval instruments. Flexible cystoscopes inserted via the Amplatz can also be helpful for cases such as complex staghorns with multiple calyceal extensions and may avoid the need for a second tract. A flexible ureteroscope can also be used antegradely to access calyces and the ureter via a PCNL tract.
Nephrostomy Drains Post PCNL
Leaving a nephrostomy drain post PCNL allows tamponade of the tract to minimize hemorrhagic complications and gives the possibility of facilitating a second-look procedure. Furthermore, if ureteric fragments are causing obstruction, the presence of a tube allows the surgeon to temporize and consider options.The drains are however uncomfortable and there has been interest therefore in tubeless PCNL. The nature of the case will determine if this approach is appropriate and a consequence may be a higher rate of stenting.
Contraindications to PCNL
There are few instances when PCNL may be inappropriate and most are patient related. The procedure can be lengthy and therefore fitness for anesthesia is important. In the morbidly obese, there can be problems in reaching the stone and skeletal problems can make access a challenge in spina bifida patients. Stone in a solitary kidney should not be considered a contraindication.